Gefapixant in two randomised dose-escalation studies in chronic cough.

Smith, Jaclyn A; Kitt, Michael M; Butera, Peter; Smith, Steven A; Li, Yuping; Xu, Zhi Jin; Holt, Kimberley; Sen, Shilpi; Sher, Mandel R; Ford, Anthony P

Smith, Jaclyn A; Kitt, Michael M; Butera, Peter; Smith, Steven A; Li, Yuping; Xu, Zhi Jin; Holt, Kimberley; Sen, Shilpi; Sher, Mandel R; Ford, Anthony P.

Afiliación

Smith JA; University of Manchester and Manchester Academic Health Science Centre, Manchester University NHS Foundation Trust, Manchester, UK.
Kitt MM; Merck & Co., Inc., Kenilworth, NJ, USA.
Butera P; Merck & Co., Inc., Kenilworth, NJ, USA.
Smith SA; Merck & Co., Inc., Kenilworth, NJ, USA jacky.smith@manchester.ac.uk.
Li Y; GetStat Solutions, LLC, Palo Alto, CA, USA.
Xu ZJ; Merck & Co., Inc., Kenilworth, NJ, USA.
Holt K; University of Manchester and Manchester Academic Health Science Centre, Manchester University NHS Foundation Trust, Manchester, UK.
Sen S; University of Manchester and Manchester Academic Health Science Centre, Manchester University NHS Foundation Trust, Manchester, UK.
Sher MR; Center for Cough, Largo, FL, USA.
Ford AP; Merck & Co., Inc., Kenilworth, NJ, USA.

Eur Respir J ; 55(3)2020 03.

Article en En | MEDLINE | ID: mdl-31949115

Asunto(s)

Tos; Pirimidinas; Enfermedad Crónica; Tos/tratamiento farmacológico; Método Doble Ciego; Humanos; Sulfonamidas; Resultado del Tratamiento

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Pirimidinas / Tos Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Revista: Eur Respir J Año: 2020 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google